Details for New Drug Application (NDA): 018118
✉ Email this page to a colleague
The generic ingredient in LANOXICAPS is digoxin. There are ten drug master file entries for this compound. Twenty-nine suppliers are listed for this compound. Additional details are available on the digoxin profile page.
Summary for 018118
Tradename: | LANOXICAPS |
Applicant: | Glaxosmithkline Llc |
Ingredient: | digoxin |
Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 018118
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | 0.2MG | ||||
Approval Date: | Jul 26, 1982 | TE: | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | 0.05MG | ||||
Approval Date: | Jul 26, 1982 | TE: | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | 0.1MG | ||||
Approval Date: | Jul 26, 1982 | TE: | RLD: | No |
Expired US Patents for NDA 018118
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Glaxosmithkline Llc | LANOXICAPS | digoxin | CAPSULE;ORAL | 018118-001 | Jul 26, 1982 | ⤷ Sign Up | ⤷ Sign Up |
Glaxosmithkline Llc | LANOXICAPS | digoxin | CAPSULE;ORAL | 018118-002 | Jul 26, 1982 | ⤷ Sign Up | ⤷ Sign Up |
Glaxosmithkline Llc | LANOXICAPS | digoxin | CAPSULE;ORAL | 018118-004 | Sep 24, 1984 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription